鈥�
Researchers involved with this research team are looking at different chemical and biological approaches to the discovery and development of cancer therapies. Chemical agents refer to synthetic molecules, small peptides or natural products, whereas biological therapies use the patient鈥檚 immune system, either directly or indirectly, to fight cancer or to lessen the side effects that may be caused by some cancer treatments. Experts in cancer biology, cancer pharmacology, organic chemistry, molecular modeling and radiobiology exploit the genomic and proteomic technologies as well as the best bioinformatics tools with the overarching goal to develop 鈥渟mart鈥� drugs against key targets for therapeutic intervention.
Theme Leader:听Dr. Jian Hui Wu, Lady Davis Institute for Medical Research, 麻豆AV
Members:
Dr. Moulay Alaoui-Jamali, Lady Davis Institute for Medical Research, 麻豆AV
Dr. Raquel Aloyz, Lady Davis Institute for Medical Research, 麻豆AV
Dr. Richard B茅liveau, Universit茅 du Quebec a Montr茅al
Dr. Katherine Borden, Universit茅 de Montr茅al
Dr. Marc Fabian, Lady Davis Institute for Medical Research, 麻豆AV
Dr. Sylvie Mader, Universit茅 de Montr茅al
Dr. Koren Mann, Lady Davis Institute for Medical Research, 麻豆AV
Dr. Thierry Muanza, Lady Davis Institute for Medical Research, 麻豆AV
Dr. Lawrence Panasci, Lady Davis Institute for Medical Research, 麻豆AV
Dr. Michael Pollak, Lady Davis Institute for Medical Research, 麻豆AV
Dr. Stephane Richard, Lady Davis Institute for Medical Research, 麻豆AV
Dr. Siham Sabri, Research Institute 麻豆AV Health Centre
Dr. Uri Saragovi, Lady Davis Institute for Medical Research, 麻豆AV
Dr. Ivan Topisirovic, Lady Davis Institute for Medical Research, 麻豆AV
Dr. Mark Trifiro, Lady Davis Institute for Medical Research, 麻豆AV
Dr. Josie Ursini-Siegel, Lady Davis Institute for Medical Research, 麻豆AV
Dr. John White, Lady Davis Institute for Medical Research, 麻豆AV
Dr. Michael Witcher, Lady Davis Institute for Medical Research, 麻豆AV
听
